Bellevue Healthcare (LON:BBH) Trading Down 1%

Posted by admin on Apr 25th, 2024

Shares of Bellevue Healthcare (LON:BBH – Get Free Report) were down 1% during trading on Wednesday . The company traded as low as GBX 142.20 ($1.76) and last traded at GBX 142.80 ($1.76). Approximately 1,316,962 shares were traded during mid-day trading, a decline of 7% from the average daily volume of 1,414,492 shares. The stock had previously closed at GBX 144.20 ($1.78).

Bellevue Healthcare Price Performance

The firm has a market cap of £780.62 million and a P/E ratio of 892.50. The firm’s 50-day moving average price is GBX 149.09 and its 200 day moving average price is GBX 142.75.

Bellevue Healthcare Announces Dividend

The company also recently announced a dividend, which will be paid on Friday, May 31st. Shareholders of record on Thursday, May 9th will be issued a GBX 3 ($0.04) dividend. This represents a dividend yield of 1.98%. The ex-dividend date of this dividend is Thursday, May 9th. Bellevue Healthcare’s payout ratio is 3,750.00%.

Insider Buying and Selling

In other Bellevue Healthcare news, insider Tony Young sold 12,156 shares of the business’s stock in a transaction dated Thursday, March 21st. The stock was sold at an average price of GBX 150 ($1.85), for a total value of £18,234 ($22,522.23). In other news, insider Tony Young sold 12,156 shares of the company’s stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of GBX 150 ($1.85), for a total transaction of £18,234 ($22,522.23). Also, insider Josephine Dixon sold 12,089 shares of the stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of GBX 146 ($1.80), for a total transaction of £17,649.94 ($21,800.82). 0.07% of the stock is currently owned by corporate insiders.

Bellevue Healthcare Company Profile

(Get Free Report)

Bellevue Healthcare Trust plc is a closed ended equity mutual fund launched by Bellevue Asset Management AG. The fund is managed by Bellevue Advisors Limited. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across healthcare sector. It seeks to benchmark the performance of its portfolio against the MSCI World Healthcare Index.